Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

2017 Pipeline Report: Trends & Projections in Biopharma

Complexity is the operative word in Pharm Exec’s 2017 Pipeline Report. Complex diseases are driving the development of new and innovative therapies while the market adjusts to manufacturing challenges and increasing drug costs. We’ve recapped some of the main topics in the report, including CAR-T therapies, combination treatments and nonalcoholic steatohepatitis (NASH), among others.  …

Cells in Motion: Macrophage Research

Macrophages play an important role in immunology, cancer, and inflammatory research. Two recent publications featured our cells to study the various effects of macrophages on killing breast cancer cells and impacting reproductive health, respectively.   Macrophage-mediated Trogocytosis Leads to Death of Antibody-opsonized Tumor Cells Velmurugan, et al. found that trogocytosis was effective in killing HER2-overexpressing…

3 Must-Attend Events at SLAS2017

With more than 5,000 attendees expected at the SLAS2017 International Conference & Exhibition in Washington, D.C. this February, there will be ample opportunities to discover, connect and grow. This year’s theme, Research: The Possibilities, will focus on the rapid evolution of the life sciences industry. From new technologies to advanced research models, the industry is…